This distinction is testament to LHWRF's dedication to excellence, transparency, and impact in the realm of social responsibility
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
Between 30-40 per cent of Covid-19 patients are either obese or diabetic
The findings, from the SPACE study, paved the way for FDA approval of AJOVY for pediatric patients aged 6-17 years weighing 45 kilograms
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding
ADHD is a common, chronic neurodevelopmental disorder that often begins in childhood and can persist into adulthood
Experts warn that illegal products may be fake, contaminated, incorrectly dosed, or contain powerful unlisted ingredients
Under his leadership, Chidamide became China’s first original small-molecule anti-tumor innovative drug and the country’s first pharmaceutical product globally licensed out
Subscribe To Our Newsletter & Stay Updated
